Skip to main content
. Author manuscript; available in PMC: 2015 Nov 25.
Published in final edited form as: Eur Urol. 2012 Feb 8;61(5):1019–1024. doi: 10.1016/j.eururo.2012.01.050

Table 1. Patient characteristics.

Age, yr
 Mean 58.3
 Median 58
 Range 34–79
Prostate-specific antigen
 Mean 5.8
 Median 4.7
 Range 0.17–97.2
Clinical stage (%)
 ≤T1c 5772 (75.5)
 T2a 1238 (16.2)
 T2b 360 (4.7)
 T2c–T3 79 (1.0)
Biopsy Gleason score (%)
 5 6 (0.1)
 3 + 3 5071 (66.3)
 3 + 4 1577 (20.6)
 4 + 3 615 (8.0)
 8 261 (3.4)
 9–10 119 (1.6)
No. of positive cores
 Mean 3.0
 Median 2
 Range 1–16
Maximum percentage of cancer per core
 Mean 43.7
 Median 40
 Range 1–100
Radical prostatectomy weight, g
 Mean 53.5
 Median 49
 Range 20–334